re: Ann: Cytopia lodges IND for JAK2 inhibito... Cytopia sure looks undervalued, but it's hard to see what's going to trigger a revaluation. And more funding is going to be needed... While uncertainty reigns, I suspect investors will prefer larger companies with more clear-cut futures.